“First money invested in the best founders.” That sentence sits on 1982 Ventures’ homepage, under two words: Early Stage.
On 26 August, DealStreetAsia reported that the Singapore firm had put Fund II money into Higgsfield’s $400 million Series B, and had offered its own network co-investment access to the round. DST Global led it. Goldman Sachs Alternatives, Intel Capital and Mirae Asset Capital sat in beside them.
The valuation was $5.4 billion, up from $1.3 billion in January.
Nobody is first money into that.
The firm broke no rule. Its duty runs to the people whose money it holds, and a stake in a business claiming $700 million in annualised revenue and thirty million users is a defensible thing to own.1 Read the deal alone and it looks like judgement.
Read it beside the homepage and it looks like appetite.
Sophrosyne is the Stoic word for temperance, and temperance here means something narrower than restraint.
Sophrosyne is the Stoic word for temperance, and temperance here means something narrower than restraint. It is the discipline of knowing which appetite belongs to you.
Seneca had to argue this in public. In the year 58, Publius Suillius Rufus attacked him for being a Stoic with a fortune, and Seneca answered in De Vita Beata.
His defence refuses the easy move. Wealth is useful, he wrote, and it brings great comfort to life; the wise man may hold it, provided he stays independent of it.
A man can own a fortune and be owned by none of it.
You know where this lands. There is a version of your week where the boring compounding business you actually run sits open in one tab, and the round everyone you follow is in sits open in the other.
The second tab is an appetite you borrowed.
The second tab is an appetite you borrowed. You picked it up because it was in the room, and it fits badly.
There is money moving through Asia right now that asks the other question.
On 25 August, Granite Asia closed Libra Hybrid at over $500 million, anchored by Temasek, Khazanah and the Indonesia Investment Authority, with DBS Private Bank among the new money. It lends to profitable mid-market companies in advanced manufacturing, consumer and healthcare, and calls the capital non-dilutive. Jenny Lee, who ran GGV’s Asia book before the firm split from its American half, calls credit a natural extension of the platform.
Credit asks one question, and the question is what you can service.
That is the sophrosyne test written as an underwriting memo, and you can run it on yourself this week with no lender in the room. Take the thing you are about to chase and name whose appetite it feeds, yours or the room’s. Then price being wrong about it in months of your own attention rather than in dollars, because attention is the account this draws on.
1982 Ventures may do very well out of Higgsfield. The mark could double again by January and no one whose money is in Fund II will complain.
What the deal costs is the sentence on the homepage, which now describes a firm that has been somewhere else.
Seneca kept his fortune and spent the rest of his life arguing that it never kept him. You get to make that argument about one appetite only, and it has to be the one you chose.
Footnotes
-
The revenue figure is Higgsfield’s own and unaudited. The steelman for 1982 Ventures is straightforward: a fund owes its returns to its limited partners rather than to a postcode or a stage label, and buying real revenue at a mark that has already quadrupled is ordinary portfolio construction. The cost sits in the marketing, not the memo. ↩